A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease
首创的 MAPK13 抑制剂,可纠正干细胞重编程和损伤后疾病
期刊:
影响因子:
doi:10.1101/2024.08.21.608990
Yong Zhang, Kangyun Wu, Dailing Mao, Courtney A Iberg, Huiqing Yin-Declue, Kelly Sun, Hallie A Wikfors, Shamus P Keeler, Ming Li, Deanna Young, Jennifer Yantis, Erika C Crouch, Joshua R Chartock, Zhenfu Han, Derek E Byers, Steven L Brody, Arthur G Romero, Michael J Holtzman